How to cite item

Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality?

   
@article{AMJ4923,
	author = {Daniele Lavacchi and Enrico Mini and Giandomenico Roviello},
	title = {Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality?},
	journal = {AME Medical Journal},
	volume = {4},
	number = {0},
	year = {2019},
	keywords = {},
	abstract = {Khalaf et al. (1) presented a sub-sequent analysis of a previously conducted phase II trial aimed to compare activity of abiraterone acetate + prednisone (AA + P) versus enzalutamide (E) in more than 200 patients with treatment-naive metastatic castration-resistant prostate cancer (2). In this study, the authors found that AA + P and E showed similar activity in terms of time to prostate-specific antigen (PSA), clinical, or radiographic progression (2).},
	issn = {2520-0518},	url = {https://amj.amegroups.org/article/view/4923}
}